Bio-Techne (TECH) Inventory (2010 - 2026)
Bio-Techne's quarterly Inventory came in at $201.2 million in Q1 2026, up 5.28% year-on-year from $191.1 million in Q1 2025, and down 2.08% quarter-over-quarter from $205.4 million in Q4 2025.
Bio-Techne has reported Inventory for 17 years, with the latest figure at $201.2 million in Q1 2026.
- For the quarter ending Q1 2026, Inventory rose 5.28% year-over-year to $201.2 million; the trailing twelve-month figure through Mar 2026 stood at $201.2 million (up 5.28% YoY), and the FY2025 full-year result was $189.4 million, up 5.41% from the prior year.
- Inventory for Q1 2026 stood at $201.2 million, down from $205.4 million in the prior quarter.
- The five-year high for Inventory was $205.4 million in Q4 2025, with the low at $128.3 million in Q1 2022.
- Average Inventory over 5 years is $177.1 million, with a median of $180.8 million recorded in 2023.
- Year-over-year, Inventory jumped 32.1% in 2023 and slipped 0.56% in 2024.
- Tracing TECH's Inventory over 5 years: stood at $160.2 million in 2022, then climbed by 12.86% to $180.8 million in 2023, then grew by 4.17% to $188.4 million in 2024, then gained by 9.06% to $205.4 million in 2025, then declined by 2.08% to $201.2 million in 2026.
- The last three Inventory figures came in at $201.2 million (Q1 2026), $205.4 million (Q4 2025), and $203.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 32.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.77 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.10 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 84.03 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | 201.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 201.18 Mn |
| Dec 31, 2025 | 205.45 Mn |
| Sep 30, 2025 | 203.19 Mn |
| Jun 30, 2025 | 189.45 Mn |
| Mar 31, 2025 | 191.08 Mn |
| Dec 31, 2024 | 188.37 Mn |
| Sep 30, 2024 | 185.04 Mn |
| Jun 30, 2024 | 179.73 Mn |
| Mar 31, 2024 | 179.50 Mn |
| Dec 31, 2023 | 180.84 Mn |
| Sep 30, 2023 | 186.08 Mn |
| Jun 30, 2023 | 171.64 Mn |
| Mar 31, 2023 | 169.46 Mn |
| Dec 31, 2022 | 160.23 Mn |
| Sep 30, 2022 | 150.01 Mn |
| Jun 30, 2022 | 141.12 Mn |
| Mar 31, 2022 | 128.28 Mn |
| Dec 31, 2021 | 121.86 Mn |
| Sep 30, 2021 | 117.37 Mn |
| Jun 30, 2021 | 116.75 Mn |
| Mar 31, 2021 | 109.99 Mn |
| Dec 31, 2020 | 106.59 Mn |
| Sep 30, 2020 | 106.00 Mn |
| Jun 30, 2020 | 103.15 Mn |
| Mar 31, 2020 | 99.67 Mn |
| Dec 31, 2019 | 95.35 Mn |
| Sep 30, 2019 | 90.86 Mn |
| Jun 30, 2019 | 91.05 Mn |
| Mar 31, 2019 | 93.84 Mn |
| Dec 31, 2018 | 90.91 Mn |
| Sep 30, 2018 | 90.92 Mn |
| Jun 30, 2018 | 85.65 Mn |
| Mar 31, 2018 | 88.59 Mn |
| Dec 31, 2017 | 68.28 Mn |
| Sep 30, 2017 | 66.53 Mn |
| Jun 30, 2017 | 85.65 Mn |
| Mar 31, 2017 | 63.77 Mn |
| Dec 31, 2016 | 66.09 Mn |
| Sep 30, 2016 | 70.52 Mn |
| Jun 30, 2016 | 57.10 Mn |
| Mar 31, 2016 | 57.07 Mn |
| Dec 31, 2015 | 58.68 Mn |
| Sep 30, 2015 | 58.97 Mn |
| Jun 30, 2015 | 49.58 Mn |
| Mar 31, 2015 | 51.05 Mn |
| Dec 31, 2014 | 52.82 Mn |
| Sep 30, 2014 | 52.20 Mn |
| Jun 30, 2014 | 38.85 Mn |
| Mar 31, 2014 | 38.39 Mn |
| Dec 31, 2013 | 39.99 Mn |
| Sep 30, 2013 | 39.96 Mn |
| Jun 30, 2013 | 34.88 Mn |
| Mar 31, 2013 | 35.68 Mn |
| Dec 31, 2012 | 37.60 Mn |
| Sep 30, 2012 | 38.40 Mn |
| Jun 30, 2012 | 38.28 Mn |
| Mar 31, 2012 | 40.50 Mn |
| Dec 31, 2011 | 40.98 Mn |
| Sep 30, 2011 | 42.12 Mn |
| Jun 30, 2011 | 44.91 Mn |
| Mar 31, 2011 | 13.62 Mn |
| Dec 31, 2010 | 13.74 Mn |
| Sep 30, 2010 | 13.82 Mn |
| Jun 30, 2010 | 13.74 Mn |